Prime Medicine, Inc. ( PRME) - Stock Earnings
PRME Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -50.6 million USD | 1.2 million USD |
| 2025Q4 | -46.1 million USD | 838000 USD |
| 2026Q1 | -49.1 million USD | 856000 USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
PRME Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -198.1 million USD | — USD |
| 2024 | -195.9 million USD | 3.0 million USD |
| 2025 | -201.1 million USD | 4.6 million USD |
| 2026 Est. | — | — |
PRME
Price: $2.92
52 week price:
Earnings Per Share: -1.23 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 542.8 million